Aldeyra Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALDX Nasdaq 2834 www.aldeyra.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aldeyra Therapeutics, Inc.

Pleasing Signs As A Number Of Insiders Buy Aldeyra Therapeutics Stock - May 5th, 2026 4:55 am
Extreme Networks And 2 Additional Stocks Estimated To Be Trading Below Their Fair Value - May 1st, 2026 11:38 am
Discover 3 Stocks That Might Be Trading Below Estimated Value - May 1st, 2026 5:38 am
3 Stocks Estimated To Be Trading Below Intrinsic Value By Up To 35.4% - Apr 29th, 2026 11:38 am
3 Stocks That May Be Trading Below Their Estimated Value In April 2026 - Apr 29th, 2026 5:38 am
April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair Value - Apr 27th, 2026 11:38 am
3 Stocks That Might Be Undervalued By Up To 32.8% - Apr 27th, 2026 5:38 am
3 Stocks That May Be Undervalued By Up To 48.1% According To Intrinsic Value Estimates - Apr 10th, 2026 11:38 am
3 Stocks Possibly Undervalued By Up To 47% Offering Potential Value - Apr 10th, 2026 5:37 am
3 Stocks That May Be Trading Below Their Estimated Intrinsic Value - Apr 9th, 2026 11:38 am
3 Stocks That May Be Undervalued In April 2026 - Apr 9th, 2026 5:37 am
Aldeyra Therapeutics And 2 More Promising Penny Stocks For Your Watchlist - Mar 25th, 2026 12:05 pm
ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA - Mar 18th, 2026 9:10 am
Aspen’s fresh Parkinson’s data; Aldeyra tanks following FDA rejection - Mar 18th, 2026 5:45 am
FDA issues CRL to Aldeyra’s reproxalap drug application - Mar 18th, 2026 4:18 am
Aldeyra Therapeutics Shares Fall Pre-Bell After US FDA Response Cites Lack of Efficacy Data for Dry Eye Drug - Mar 17th, 2026 7:17 am
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease - Mar 17th, 2026 6:30 am
SSR Mining Stock Up 180% as New $5 Million Stake Signals Gold Conviction - Mar 3rd, 2026 2:10 pm
Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy - Mar 3rd, 2026 1:57 pm
Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year? - Feb 26th, 2026 7:40 am